Abstract
The proto-oncogene c-kit encodes a transmembrane tyrosine kinase growth factor receptor. Stem cell factor, the receptor ligand, plays an important role in the development of certain neoplasms. c-kit is selectively and competitively bound by STI-571, a newly developed tyrosine kinase inhibitor. Several investigators report conflicting results concerning its expression, especially in malignant breast lesions. The objective of this study was to better characterize the expression of c-kit within the spectrum of breast epithelium (normal breast epithelium, nonneoplastic lesions, and breast carcinoma). Seventy-seven randomly selected breast tissue samples, each containing normal breast epithelium (21), invasive breast carcinoma (41), in situ breast carcinoma (29), papilloma (8), fibroadenoma (5), fibrocystic change (11), and/or metastatic breast carcinoma (4), were immunostained with polyclonal rabbit antihuman c-kit (Dako, Carpenteria, CA) at a dilution of 1:200. The staining was interpreted as negative if no cells were immunoreactive, weak positive if 5% of the cells were immunoreactive, and positive if more than 5% of the cells were immunoreactive. Appropriate positive and negative controls were used. The observed staining was cyt...Continue Reading
References
Nov 11, 1992·International Journal of Cancer. Journal International Du Cancer·P G NataliA Ullrich
Jan 1, 1994·Virchows Archiv : an International Journal of Pathology·Y TsuuraT Seito
Nov 1, 1994·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A LammieC Cordon-Cardo
Jan 1, 1994·Virchows Archiv : an International Journal of Pathology·Y SumiyoshiY Minamishima
May 1, 1996·British Journal of Cancer·X ChuiM Ogawa
Oct 24, 1997·The Journal of Allergy and Clinical Immunology·H VliagoftisD D Metcalfe
Aug 3, 2000·Oncogene·W L WangR Salgia
Dec 6, 2000·The Journal of Surgical Research·C M ChenH J Harn
Apr 5, 2001·The New England Journal of Medicine·H JoensuuG D Demetri
Jun 26, 2001·The Oncologist·M J Mauro, B J Druker
Jul 17, 2001·Journal of Internal Medicine·M E O'Dwyer, B J Druker
Jan 5, 2002·Advances in Anatomic Pathology·Pamela C Gibson, Kumarasen Cooper
May 25, 2002·Journal of Cancer Research and Clinical Oncology·Y TsuuraM Sano
Citations
Sep 13, 2007·Medical Oncology·Aydan Eroğlu, Aliye Sari
Jun 29, 2013·Cellular Oncology (Dordrecht)·Sara BravacciniDino Amadori
May 27, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Bojana Djordjevic, Wedad M Hanna
Jul 1, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Joseph T RabbanYunn Yi Chen
Nov 9, 2010·Oncogene·P PittoniM P Colombo
Jun 3, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M CristofanilliG N Hortobagyi
Oct 6, 2005·American Journal of Clinical Pathology·Giovanna M CrisiRobert A Goulart
May 31, 2011·Reproductive Toxicology·Laura E WrightJanet L Funk
Dec 17, 2008·Clinical Breast Cancer·Helen K ChewRobert Livingston
Oct 13, 2007·Pathology, Research and Practice·Ayse Polat
Jun 21, 2005·Journal of Cellular and Molecular Medicine·L M PopescuM E Hinescu
Aug 30, 2008·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Hawa NalwogaLars A Akslen
Jun 10, 2015·Journal of Clinical Pathology·John TawasilGary M Tse
Jun 12, 2016·Virchows Archiv : an International Journal of Pathology·Trine TrammFattaneh A Tavassoli
Feb 5, 2014·International Journal of Surgical Pathology·Maria Helena Tavares VilelaMarise Amaral Rebouças Moreira
May 25, 2006·British Journal of Cancer·S TsutsuiS Era
Mar 1, 2018·Oncotarget·Ilaria MarechGirolamo Ranieri
Nov 28, 2017·Oncogenesis·J Chuck HarrellBritta M Jacobsen
Oct 31, 2018·Marine Drugs·Djenisa H A RochaDiana C G A Pinto
Jun 1, 2018·Experimental and Molecular Pathology·Radoslav JanostiakMalini Harigopal